\-\ Texto\\:\\ \ \(0\)\
\-\ decrease\\ level\\ of\\ consciousness\ \(0\)\
\-\ \\â\\€\\¢\\ antihypertensive\\ therapy\ \(0\)\
\-\ \\â\\€\\¢\\ intubation\\ and\\ supportive\\ measures\ \(0\)\
\-\ \\â\\€\\¢\\ ct\\-\\-\\ high\\ attenuation\\ lesion\\ in\\ the\\ central\\ pons\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mri\\-\\-pontine\\ lesion\\ with\\ minimal\\ signal\\ intensity\\ change\\ on\\ t1\\ and\\ t2\\ scans\\.\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ contrast\\ enhancement\\.\ \(0\)\
\-\ pontine\\ hypertensive\\ hemorrhage\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ avm\ \(0\)\
\-\ \\â\\€\\¢\\ vasculitis\ \(1\)\
\-\ \\â\\€\\¢\\ hypertensive\\ vascular\\ disease\ \(0\)\
\-\ 53\\ year\\ old\\ woman\\ with\\ history\\ of\\ uncontrolled\\ hypertension\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pontine\\:\\ 0\\.40348384236824897\ \(0\)\
\-\ hypertensive\\:\\ 0\\.36660102691318275\ \(0\)\
\-\ antihypertensive\\:\\ 0\\.2482823164929167\ \(0\)\
\-\ uncontrolled\\:\\ 0\\.21793269401774887\ \(0\)\
\-\ intubation\\:\\ 0\\.19746716020525376\ \(0\)\
\-\ pons\\:\\ 0\\.18146178528659215\ \(0\)\
\-\ lesion\\:\\ 0\\.16924477887091277\ \(0\)\
\-\ 53\\:\\ 0\\.16518298161283118\ \(0\)\
\-\ consciousness\\:\\ 0\\.16483334151488227\ \(0\)\
\-\ vasculitis\\:\\ 0\\.16380751874991384\ \(0\)\
\-\ avm\\:\\ 0\\.156105973295941\ \(0\)\
\-\ scans\\:\\ 0\\.15358890986227214\ \(0\)\
\-\ decrease\\:\\ 0\\.15171301313592658\ \(0\)\
\-\ disease\\:\\ 0\\.14818449988503543\ \(0\)\
\-\ supportive\\:\\ 0\\.14746762360628324\ \(0\)\
\-\ measures\\:\\ 0\\.1439113663995081\ \(0\)\
\-\ attenuation\\:\\ 0\\.13505390760834257\ \(0\)\
\-\ hypertension\\:\\ 0\\.13505390760834257\ \(0\)\
\-\ minimal\\:\\ 0\\.1346580452441154\ \(0\)\
\-\ change\\:\\ 0\\.13375359782350665\ \(0\)\
\-\ intensity\\:\\ 0\\.12533313890767572\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.11817727198002151\ \(0\)\
\-\ central\\:\\ 0\\.11787090492836348\ \(0\)\
\-\ vascular\\:\\ 0\\.11652859627352286\ \(0\)\
\-\ t1\\:\\ 0\\.10997619962636966\ \(0\)\
\-\ level\\:\\ 0\\.10662171027729281\ \(0\)\
\-\ enhancement\\:\\ 0\\.10159556571404046\ \(0\)\
\-\ t2\\:\\ 0\\.10155055796874127\ \(0\)\
\-\ therapy\\:\\ 0\\.10141592619969367\ \(0\)\
\-\ high\\:\\ 0\\.1003162077775191\ \(0\)\
\-\ signal\\:\\ 0\\.10005799081780886\ \(0\)\
\-\ metastatic\\:\\ 0\\.09680641201146761\ \(0\)\
\-\ woman\\:\\ 0\\.0919265167674534\ \(0\)\
\-\ mri\\:\\ 0\\.0906041106322836\ \(0\)\
\-\ contrast\\:\\ 0\\.0857621681713769\ \(0\)\
\-\ and\\:\\ 0\\.07294688933611246\ \(0\)\
\-\ with\\:\\ 0\\.06912537721668417\ \(0\)\
\-\ of\\:\\ 0\\.06908409948370449\ \(0\)\
\-\ history\\:\\ 0\\.06743669470999418\ \(0\)\
\-\ ct\\:\\ 0\\.06719867184832438\ \(0\)\
\-\ no\\:\\ 0\\.05739875110095743\ \(0\)\
\-\ year\\:\\ 0\\.054396629670571836\ \(0\)\
\-\ on\\:\\ 0\\.0533087781436285\ \(0\)\
\-\ old\\:\\ 0\\.052239594344402084\ \(0\)\
\-\ in\\:\\ 0\\.04390973580926239\ \(0\)\
\-\ the\\:\\ 0\\.03521996133989159\ \(0\)\
